Post-exposure rabies prophylaxis: establishing effectiveness of abbreviated treatments.
Several publications have reported recently the apparently successful use of human diploid cell rabies vaccine (HDCV) in volumes of less than the 6 X 1.0 cm3 dosage schedule currently recommended by the World Health Organization for post-exposure rabies prophylaxis. The newer proposed treatments are advocated to economize on an expensive product that may be available rarely in many Third World areas.
D000818:Animals; D001733:Bites and Stings; D004285:Dogs; D006801:Humans; D011818:Rabies / Q000517:prevention & control*; D011819:Rabies Vaccines / Q000008:administration & dosage*
D011819:Rabies Vaccines